• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三叶因子家族在接受胃保护性药物用于低剂量乙酰水杨酸胃肠道损伤一级预防的貌似健康受试者中的作用:一项初步研究。

The role of trefoil factor family in apparently healthy subjects administrated gastroprotective agents for the primary prevention of gastrointestinal injuries from low-dose acetylsalicylic acid: a preliminary study.

机构信息

Endoscopy Center, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.

出版信息

J Clin Biochem Nutr. 2011 Sep;49(2):136-40. doi: 10.3164/jcbn.11-10. Epub 2011 Aug 25.

DOI:10.3164/jcbn.11-10
PMID:21980231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3171679/
Abstract

It is well-known that acetylsalicylic acid induces gastrointestinal complication. Recently, trefoil factor family has been reported as a mucosal protective factor. We focused on trefoil factor family as one of defensive system for gastrointestinal injuries. The aim of this trial was to evaluate trefoil factor family levels in the serum of healthy subjects with low-dose acetylsalicylic acid. Low-dose acetylsalicylic acid with placebo or proton pump inhibitor or rebamipide were administered in 30 healthy subjects. Transnasal endoscopy was performed at 0, 24 h, 3 and 7 day. Changing of trefoil factor family (1,2,3) and numbers of gastric injuries were evaluated. The numbers of gastric injuries were significantly increased in the placebo group at 3 and 7 days. Injuries in the proton pump inhibitor group were not induced, in the rebamipide group were slightly induced. Trefoil factor family level in the placebo group were decreased in 3 and 7 days compared with prior to starting the trial. Trefoil factor family may have an important association with acetylsalicylic acid-induced gastrointestinal damage. Proton pump inhibitor and rebamipide prevented low-dose acetylsalicylic acid-induced gastrointestinal complications compared with the placebo group.

摘要

众所周知,乙酰水杨酸会引起胃肠道并发症。最近,三叶因子家族已被报道为一种黏膜保护因子。我们将三叶因子家族作为胃肠道损伤防御系统之一进行了研究。本试验旨在评估低剂量乙酰水杨酸对健康受试者血清三叶因子家族水平的影响。30 名健康受试者分别给予低剂量乙酰水杨酸+安慰剂、质子泵抑制剂或瑞巴派特,于 0、24h、3d 和 7d 行经鼻内镜检查,评估三叶因子家族(1、2、3)变化和胃损伤数量。安慰剂组在 3d 和 7d 时胃损伤数量明显增加,质子泵抑制剂组未诱导出损伤,瑞巴派特组仅轻度诱导出损伤。与试验前相比,安慰剂组在 3d 和 7d 时三叶因子家族水平降低。三叶因子家族可能与乙酰水杨酸引起的胃肠道损伤有重要关系。与安慰剂组相比,质子泵抑制剂和瑞巴派特可预防低剂量乙酰水杨酸引起的胃肠道并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bc5/3171679/f319b0167b9a/jcbn11-10f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bc5/3171679/f319b0167b9a/jcbn11-10f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bc5/3171679/f319b0167b9a/jcbn11-10f01.jpg

相似文献

1
The role of trefoil factor family in apparently healthy subjects administrated gastroprotective agents for the primary prevention of gastrointestinal injuries from low-dose acetylsalicylic acid: a preliminary study.三叶因子家族在接受胃保护性药物用于低剂量乙酰水杨酸胃肠道损伤一级预防的貌似健康受试者中的作用:一项初步研究。
J Clin Biochem Nutr. 2011 Sep;49(2):136-40. doi: 10.3164/jcbn.11-10. Epub 2011 Aug 25.
2
Circadian variations of gastrointestinal mucosal damage detected with transnasal endoscopy in apparently healthy subjects treated with low-dose aspirin (ASA) for a short period.在短期接受低剂量阿司匹林(ASA)治疗的貌似健康受试者中,经鼻内镜检查检测到的胃肠道黏膜损伤的昼夜变化。
J Atheroscler Thromb. 2009 Jun;16(3):155-63. doi: 10.5551/jat.e615. Epub 2009 Jun 25.
3
Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study.雷贝拉唑预防健康受试者小剂量阿司匹林性胃损伤的初步临床试验:一项随机、双盲、安慰剂对照、交叉研究。
J Clin Biochem Nutr. 2009 Sep;45(2):248-53. doi: 10.3164/jcbn.09-24. Epub 2009 Aug 28.
4
Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury.胃黏膜保护药物瑞巴派特预防低剂量阿司匹林所致胃肠道黏膜损伤的合适剂量的确定。
J Clin Biochem Nutr. 2016 Nov;59(3):231-237. doi: 10.3164/jcbn.16-49. Epub 2016 Oct 7.
5
Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats.瑞巴派特对大鼠胃酸分泌刺激下阿司匹林加氯吡格雷所致胃出血及致溃疡反应的影响。
J Gastroenterol Hepatol. 2014 Dec;29 Suppl 4:37-46. doi: 10.1111/jgh.12774.
6
Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms.雷贝拉唑治疗小剂量阿司匹林相关胃肠道症状的疗效。
J Clin Biochem Nutr. 2012 Nov;51(3):216-20. doi: 10.3164/jcbn.12-27. Epub 2012 Aug 10.
7
Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial.瑞巴派特不能预防萘普生引起的胃损伤:一项随机双盲对照试验。
BMC Gastroenterol. 2016 Jun 4;16(1):58. doi: 10.1186/s12876-016-0472-x.
8
Evaluation of gastrointestinal injury and blood flow of small bowel during low-dose aspirin administration.评价小剂量阿司匹林给药期间的胃肠道损伤和血流情况。
J Clin Biochem Nutr. 2011 May;48(3):245-50. doi: 10.3164/jcbn.10-112. Epub 2011 Apr 13.
9
A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage.一项关于高剂量瑞巴派特治疗低剂量阿司匹林所致中重度小肠损伤的多中心、随机、双盲、安慰剂对照试验。
PLoS One. 2015 Apr 15;10(4):e0122330. doi: 10.1371/journal.pone.0122330. eCollection 2015.
10
Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.瑞巴派特对健康受试者双氯芬酸所致小肠黏膜损伤的疗效:一项前瞻性、随机、双盲、安慰剂对照、交叉研究。
J Gastroenterol. 2008;43(4):270-6. doi: 10.1007/s00535-007-2155-4. Epub 2008 May 6.

引用本文的文献

1
Human Trefoil Factor 3 induces the transcription of its own promoter through STAT3.人三叶因子3通过信号转导子和转录激活子3诱导其自身启动子的转录。
Sci Rep. 2016 Jul 25;6:30421. doi: 10.1038/srep30421.
2
Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis.雷贝拉唑有助于预防非甾体抗炎药引起的胃肠道疾病:系统评价和荟萃分析。
Dig Dis Sci. 2013 Jul;58(7):1991-2000. doi: 10.1007/s10620-013-2606-0. Epub 2013 Feb 28.
3
Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms.

本文引用的文献

1
European physicians don't like cytoprotective agents?欧洲医生不喜欢细胞保护剂吗?
J Clin Biochem Nutr. 2011 Jul;49(1):67. doi: 10.3164/jcbn.10-140. Epub 2011 May 10.
2
Gastroduodenal mucosal injury in patients taking low-dose aspirin and the role of gastric mucoprotective drugs: possible effect of rebamipide.在服用小剂量阿司匹林的患者中,胃十二指肠黏膜损伤和胃黏膜保护药物的作用:可能的瑞巴派特的作用。
J Clin Biochem Nutr. 2010 Jul;47(1):27-31. doi: 10.3164/jcbn.09-103. Epub 2010 Jun 17.
3
Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study.
雷贝拉唑治疗小剂量阿司匹林相关胃肠道症状的疗效。
J Clin Biochem Nutr. 2012 Nov;51(3):216-20. doi: 10.3164/jcbn.12-27. Epub 2012 Aug 10.
雷贝拉唑预防健康受试者小剂量阿司匹林性胃损伤的初步临床试验:一项随机、双盲、安慰剂对照、交叉研究。
J Clin Biochem Nutr. 2009 Sep;45(2):248-53. doi: 10.3164/jcbn.09-24. Epub 2009 Aug 28.
4
Circadian variations of gastrointestinal mucosal damage detected with transnasal endoscopy in apparently healthy subjects treated with low-dose aspirin (ASA) for a short period.在短期接受低剂量阿司匹林(ASA)治疗的貌似健康受试者中,经鼻内镜检查检测到的胃肠道黏膜损伤的昼夜变化。
J Atheroscler Thromb. 2009 Jun;16(3):155-63. doi: 10.5551/jat.e615. Epub 2009 Jun 25.
5
The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy.阿司匹林所致消化性溃疡的预防因素:阿司匹林溃疡与胃体萎缩。
J Gastroenterol. 2009;44(7):717-25. doi: 10.1007/s00535-009-0068-0. Epub 2009 May 16.
6
A questionnaire-based survey on the prescription of non-steroidal anti-inflammatory drugs by physicians in East Asian countries in 2007.2007年东亚国家医生开具非甾体抗炎药处方情况的问卷调查
Digestion. 2009;79(3):177-85. doi: 10.1159/000211713. Epub 2009 Apr 3.
7
Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease.缺血性心脏病患者低剂量阿司匹林所致胃十二指肠黏膜损伤的内镜检查
J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S234-6. doi: 10.1111/j.1440-1746.2008.05411.x.
8
Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test.瑞巴派特,一种细胞保护药物,可增加人体胃黏液分泌:内镜胃泌素试验评估。
Dig Dis Sci. 2009 Jul;54(7):1500-7. doi: 10.1007/s10620-008-0507-4. Epub 2008 Oct 31.
9
Clinical implications of clopidogrel resistance.氯吡格雷抵抗的临床意义。
Thromb Haemost. 2008 Aug;100(2):196-203.
10
The role of aspirin in cardiovascular prevention: implications of aspirin resistance.阿司匹林在心血管疾病预防中的作用:阿司匹林抵抗的影响
J Am Coll Cardiol. 2008 May 13;51(19):1829-43. doi: 10.1016/j.jacc.2007.11.080.